Acellular Human Nerve Allografts as a Means to Decrease Sensory Deficits following Peripheral Nerve Biopsy
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Rochester, Minnesota: 15-008409
Sponsor Protocol Number: 15-008409
About this study
The ourpose of this study is to Investigate the effectiveness of acellular human nerve allografts in decreasing sensory deficits following peripheral nerve biopsy.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
- Individual is scheduled to have a peripheral nerve biopsy.
- Individual will undergo peripheral nerve harvest for facial re-animation surgery
- Age above 18 years old.
- Patient refuses to give informed consent for study
- Any evidence of neurological deficit affecting the area supplied by biopsied nerve
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Samir Mardini, M.D.
Closed for enrollment
Publications are currently not available
Study Results Summary
Not yet available
Supplemental Study Information
Not yet available